Advertisement

Topics

NCPA statement on nomination of Alex Azar to be HHS Secretary

13:51 EST 14 Nov 2017 | CentreWatch

National Community Pharmacists Association CEO B. Douglas Hoey, Pharmacist, MBA, issued the following statement on President Donald Trump’s nomination of Alex Azar, a former executive at Eli Lilly & Co., to lead the U.S. Department of Health and Human Services: “We congratulate Alex Azar on his nomination to be the next HHS Secretary. His background […]

The post NCPA statement on nomination of Alex Azar to be HHS Secretary appeared first on CenterWatch News Online.

Original Article: NCPA statement on nomination of Alex Azar to be HHS Secretary

NEXT ARTICLE

More From BioPortfolio on "NCPA statement on nomination of Alex Azar to be HHS Secretary"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Pharmacy
Pharmacy is the science and technique of preparing as well as dispensing drugs and medicines. It is a health profession that links health sciences with chemical sciences and aims to ensure the safe and effective use of pharmaceutical drugs. The scope of...

The Top 100 Pharmaceutical Companies
Top 10 biotech and pharmaceutical companies worldwide based on market value in 2015 2015 ranking of the global top 10 biotech and pharmaceutical companies based on revenue (in billion U.S. dollars) Johnson & Johnson, U.S. 74...